Impact of Achieving ASDAS LDA on Disease Activity and Patient-Reported Outcome Measures Among Patients with Ankylosing Spondylitis Treated with Biologic DMARDs - ACR Meeting Abstracts
Descrição
Background/Purpose: Although Ankylosing Spondylitis Disease Activity Score (ASDAS) low disease activity (LDA) is a common treatment target for disease control when managing AS, real-world research describing ASDAS LDA achievement among patients treated with biologic DMARDs (bDMARD) is limited. The aim of this study was to describe disease activity and patient-reported outcome measures (PROMs) among patients […]
Dose reduction and withdrawal strategy for TNF-inhibitors in
ACR23 SpA Research for the SAA Spondyloarthritis Community - My
Safety Profile, Axial Spondyloarthritis
PDF) Multi-biomarker disease activity score as a predictor of
Validation of the Ankylosing Spondylitis Disease Activity Score
PDF) Development and preselection of criteria for short term
PDF) Recommendations of the French Society for Rheumatology. TNFα
Treating to Target(s) With Interleukin-17 Inhibitors - Charles W
Impact of tapering targeted therapies (bDMARDs or JAKis) on the
Sex differences in the effectiveness of first-line tumour necrosis
Full article: POSTER PRESENTATIONS
Ankylosing Spondylitis Disease Activity Score (ASDAS): 2018 update
de
por adulto (o preço varia de acordo com o tamanho do grupo)
